Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity

Radiotherapy and Oncology

Volumn 40, Issue 2, 1996, Pages 137-145

  Maciejewski, Boguslaw ^a   Skladowski, Krzysztof ^a   Pilecki, Boleslaw ^a   Taylor, Jeremy M G ^b,c   Withers, Rodney H ^c   Miszczyk, Leszek ^a   Zajusz, Aleksander ^a   Suwinski, Rafal ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Accelerated fractionation 7 days per week; Confluent mucositis; Consequential late effects

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; TOXICITY;

EID: 0030220905     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-8140(96)01776-8     Document Type: Article

References (23)

1. [1] Ang, K.K., Peters, L.J., Weber, R.S., et al. Concomitant boost radiotherapy schedule in the treatment of carcinoma of the oropharynx and nasopharynx. Int. J. Radiat. Oncol. Biol. Phys. 19: 1339-1345, 1990.
2. [2] Dische, S.A., Warburton, M.F., Jones, D., et al. The recording of morbidity related to radiotherapy. Radiother. Oncol. 16: 103-108, 1989.
3. [3] Fletcher, G.H. Textbook in radiotherapy, 3rd Edn. Lea and Febiger, Philadelphia, 1980.
4. [4] International Commission on Radiation Units and measurements: Dose specification for reporting external beam therapy with photons and electrons. Report 29, ICRU Publications, Washington DC, 1988.
5. [5] Kaanders, J.H.A.M., Van Daal, W.A.J., Hoogenraad, W.J. and Van der Kogel, A.J. Accelerated fractionation radiotherapy for laryngeal cancer, acute and late toxicity. Int. J. Radiat. Oncol. Biol. Phys. 24: 497-503, 1992.
6. [6] Lamb, D., Spry, N., Gray, A.J. et al. Accelerated fractionation radiotherapy for advanced head and neck cancer. Radiother. Oncol. 18: 107-116, 1990.
7. [7] Leunens, G., van Dam, J., Dutreix, A. and van der Schueren, E. Quality assurance in radiotherapy by in vivo dosimetry. 1. Entrance dose measurements, a reliable procedure. Radiother. Oncol. 17: 141-151, 1990.
8. [8] Leunens, G., van Dam, J., Dutreix, A. and van der Schueren, E. Quality assurance in radiotherapy by in vivo dosimetry. 2. Determination of the absorbed dose. Radiother. Oncol. 19: 73-87, 1990.
9. [9] Maciejewski, B., Zajusz, A., Pilecki, B., et al. Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancers. Radiother. Oncol. 22: 7-11, 1991.
10. [10] Michalowski, A. On radiation damage to normal tissues and its treatment. 1. Growth factors. Acta Oncol. 29: 1017-1023, 1990.
11. [11] Nguyen, T., Demange, L., Froissart, D., et al. Rapid hyperfractionated radiotherapy. Clinical results in 178 advanced squamous cell carcinomas of the head and neck. Cancer 56: 16-19, 1985.
12. [12] Olmi, P., Celai, E., Chiavacci, A., et al. Accelerated fractionation radiotherapy for advanced head and neck cancer. Radiother. Oncol. 17: 199-207, 1990.
13. [13] Peracchia, J.T., Salti, C. Radiotherapy with thrice-a-day fractionation in a short overall time. Clinical experience. Int. J. Radiat. Oncol. Biol. Phys. 7: 99-104, 1981.
14. [14] Peters, L.J., Ang, K.K. and Thames, H.D. Accelerated fractionation in the radiation treatment of head and neck cancer: A critical comparison of different strategies. Acta Oncol. 27: 185-194, 1988.
15. [15] Peters, L.J., Ang, K.K. The role of altered fractionation in head and neck cancers. Semin. Radiat. Oncol. 2: 180-194, 1992.
16. 60Co beams, by means of direct measurement on the incident and on the exit surfaces. Radiother. Oncol. 3: 279-283, 1985.
17. [17] Saunders, M.J., Dische, S., Grosch, E.J., et al. Experience with CHART. Int. J. Radiat. Oncol. Biol. Phys. 21: 871-878, 1991.
18. [18] Svoboda, V. Accelerated fractionation: The Portsmounth experience 1971-1984. In: Proceedings of Varian Fourth European Clinac Users Meeting, Malta, May 25-26, 1984, pp. 70-75. Varian, Switzerland, 1984.
19. [19] Thames, H.D., Withers, H.R., Peters, L.J. and Fletcher, G.H. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int. J. Radiat. Oncol. Biol. Phys. 8: 219-226, 1982.
20. [20] Van der Schueren, E., van der Bogaert, W., Vanuytsel, L., et al. Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa. Int. J. Radiat. Oncol. Biol. Phys. 19: 301-311, 1990.
21. [21] Wang, C.C. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes. Int. J. Radiat. Oncol. Biol. Phys. 14: 1143-1146, 1988.
22. [22] Withers, H.R. Treatment induced accelerated human tumour growth. Semin. Radiat. Oncol. 3: 135-143, 1993.
23. [23] Withers, H.R., Taylor, J.M.G. and Maciejewski, B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol. 27: 131-146, 1988.